FORA Capital LLC Has $3.45 Million Stake in Danaher Corporation $DHR

Key Points

• FORA Capital LLC significantly increased its stake in Danaher Corporation by 108.1% in the first quarter, acquiring an additional 8,750 shares, bringing its total holdings to 16,847 shares valued at approximately $3.45 million.
• Analysts have recently updated their price targets for Danaher, with Scotiabank raising its target to $275.00 while Deutsche Bank and UBS have reduced theirs to $235.00 and $225.00, respectively.
• Danaher Corporation reported earnings per share (EPS) of $1.80 for the last quarter, surpassing expectations and reflecting a 3.4% increase in revenue year-over-year.

FORA Capital LLC increased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 108.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,847 shares of the conglomerate's stock after buying an additional 8,750 shares during the period. FORA Capital LLC's holdings in Danaher were worth $3,454,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. FAS Wealth Partners Inc. raised its stake in shares of Danaher by 20.6% during the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after buying an additional 1,639 shares during the last quarter. MGO One Seven LLC raised its stake in shares of Danaher by 485.7% during the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after buying an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher in the first quarter valued at approximately $539,000. Horizon Financial Services LLC increased its stake in Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after purchasing an additional 8,160 shares in the last quarter. Finally, Texas Capital Bank Wealth Management Services Inc increased its stake in Danaher by 6.1% in the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate's stock valued at $7,126,000 after purchasing an additional 2,009 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several recent analyst reports. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research note on Friday, July 11th. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Wells Fargo & Company lowered their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Evercore ISI lowered their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Finally, UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research note on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Stock Up 0.4%

Danaher stock traded up $0.80 during mid-day trading on Friday, reaching $206.09. The company's stock had a trading volume of 1,979,809 shares, compared to its average volume of 3,319,294. The company has a market capitalization of $147.57 billion, a price-to-earnings ratio of 43.85, a price-to-earnings-growth ratio of 2.87 and a beta of 0.73. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The business's 50 day simple moving average is $201.65 and its 200 day simple moving average is $199.49. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.